Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Koerper

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
The Journal of Pediatrics|November 1, 1983
Immunologic abnormalities in patients with hemophilia AP S Weintrub, M A Koerper, J E Addiego, et al.
BMJ (Clinical Research Ed.)|January 25, 1992
Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study GroupL M Aledort, M W Hilgartner, M C Pike, et al.
The New England Journal of Medicine|February 11, 1993
Low CD4+ counts in a study of transfusion safety. The Transfusion Safety Study GroupL M Aledort, E A Operskalski, S L Dietrich, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest riskE C Thorland, J B Drost, J M Lusher, et al.
Pediatrics|August 1, 1991
Risk of human immunodeficiency virus type 1 infection among sexual and nonsexual household contacts of persons with congenital clotting disordersJ M Lusher, E A Operskalski, L M Aledort, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Factor IX inhibitors and anaphylaxis in haemophilia BI Warrier, B M Ewenstein, M A Koerper, et al.
Vox Sanguinis|January 1, 1990
Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study GroupS L Dietrich, J W Mosley, J M Lusher, et al.
Journal of Pediatric Hematology/Oncology|March 1, 1997
One course versus two courses of antithymocyte globulin for the treatment of severe aplastic anemia in childrenY H Matloub, C Smith, B Bostrom, et al.
Human Genetics|January 27, 2000
Germline origins in the human F9 gene: frequent G:C-->A:T mosaicism and increased mutations with advanced maternal ageR P Ketterling, E Vielhaber, X Li, et al.
Journal of Pediatric Hematology/Oncology|January 1, 1997
Factor IX inhibitors and anaphylaxis in hemophilia BI Warrier, B M Ewenstein, M A Koerper, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Pediatrics|November 1, 1983
Immunologic abnormalities in patients with hemophilia AP S Weintrub, M A Koerper, J E Addiego, et al.
BMJ (Clinical Research Ed.)|January 25, 1992
Variability in serial CD4 counts and relation to progression of HIV-I infection to AIDS in haemophilic patients. Transfusion Safety Study GroupL M Aledort, M W Hilgartner, M C Pike, et al.
The New England Journal of Medicine|February 11, 1993
Low CD4+ counts in a study of transfusion safety. The Transfusion Safety Study GroupL M Aledort, E A Operskalski, S L Dietrich, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 24, 1999
Anaphylactic response to factor IX replacement therapy in haemophilia B patients: complete gene deletions confer the highest riskE C Thorland, J B Drost, J M Lusher, et al.
Pediatrics|August 1, 1991
Risk of human immunodeficiency virus type 1 infection among sexual and nonsexual household contacts of persons with congenital clotting disordersJ M Lusher, E A Operskalski, L M Aledort, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 24, 2016
Factor IX inhibitors and anaphylaxis in haemophilia BI Warrier, B M Ewenstein, M A Koerper, et al.
Vox Sanguinis|January 1, 1990
Transmission of human immunodeficiency virus type 1 by dry-heated clotting factor concentrates. Transfusion Safety Study GroupS L Dietrich, J W Mosley, J M Lusher, et al.
Journal of Pediatric Hematology/Oncology|March 1, 1997
One course versus two courses of antithymocyte globulin for the treatment of severe aplastic anemia in childrenY H Matloub, C Smith, B Bostrom, et al.
Human Genetics|January 27, 2000
Germline origins in the human F9 gene: frequent G:C-->A:T mosaicism and increased mutations with advanced maternal ageR P Ketterling, E Vielhaber, X Li, et al.
Journal of Pediatric Hematology/Oncology|January 1, 1997
Factor IX inhibitors and anaphylaxis in hemophilia BI Warrier, B M Ewenstein, M A Koerper, et al.
Pageof 5